Multiple Myeloma Comprehensive Profile Test sale cost 3510 AED
Spino Cerebral Ataxia SCA Panel - 1 2 3 6 7 10 and 12 Test sale cost 3000 AED Spino Cerebral Ataxia SCA Panel - 1 2 3 6 7 10 and 12 Test Cost 4,000 د.إ Original price was: 4,000 د.إ.3,000 د.إCurrent price is: 3,000 د.إ.
Interleukin-6 IL-6 SARS-CoV-2 Advanced Panel Test sale cost 3280 AED Interleukin-6 IL-6 SARS-CoV-2 Advanced Panel Test Cost 3,640 د.إ Original price was: 3,640 د.إ.3,280 د.إCurrent price is: 3,280 د.إ.
Sale!

Multiple Myeloma Comprehensive Profile Test Cost

Original price was: 3,900 د.إ.Current price is: 3,510 د.إ.

-10%

The Multiple Myeloma Comprehensive Profile Test is a specialized diagnostic evaluation designed to provide a detailed analysis of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This test is crucial for the accurate diagnosis, prognosis, and monitoring of the disease, enabling healthcare providers to tailor the most effective treatment plans for their patients.

Performed at DNA Labs UAE, a leading facility in medical diagnostics, the test encompasses a range of assays and analyses to assess the genetic and molecular aspects of the cancer cells, as well as their impact on the patient’s immune system and overall health. The comprehensive nature of the test allows for the detection of specific biomarkers and abnormalities associated with multiple myeloma, including but not limited to, chromosomal abnormalities, protein levels, and the presence of monoclonal proteins.

The cost of the Multiple Myeloma Comprehensive Profile Test is set at 3510 AED, reflecting the extensive resources, advanced technology, and expertise required to conduct this in-depth examination. By investing in this test, patients and their healthcare teams gain valuable insights into the specific characteristics of the myeloma, which is instrumental in developing a personalized treatment approach aimed at achieving the best possible outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MULTIPLE MYELOMA COMPREHENSIVE PROFILE Test

Test Name: MULTIPLE MYELOMA COMPREHENSIVE PROFILE Test

Components:

  • CBC
  • Urea
  • Creatinine
  • Calcium, total
  • Albumin
  • LDH
  • Beta 2 Microglobulin
  • Protein electrophoresis, serum
  • Immunotyping, serum
  • Kappa / Lambda Light Chains Free, serum
  • Immunoglobulin Profile, serum
  • MRD for Multiple Myeloma

Price: 3510.0 AED

Sample Condition: 5 mL (3 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Overnight fasting is preferred AND 3 mL (1 mL min.) Bone Marrow (first pull aspirate) in 1 Green Top (Sodium Heparin) tube AND 1 or 2 unstained Bone marrow smears to be made at source. Mix thoroughly & Ship immediately at 18-22°C or at 4-8°C. DO NOT FREEZE. Following information is mandatory: Sample time point (Chemotherapy time points); Previous diagnostic immunophenotype report; Clinical History to include if patient is on anti-CD38 therapy; Original TRF; Date and time when sample was drawn.

Report Delivery: Sample Daily by 9 am; Report 3 Working days

Method: Capillary electrophoresis, Agarose Gel Electrophoresis, Immunoturbidimetry, CLIA Spectrophotometry, Electrical impedance, VCS Nephelometry, Flow cytometry

Test type: Multiple Myeloma

Doctor: Oncologist

Test Department: FLOW CYTOMETRY

Pre Test Information: Overnight fasting preferred. Following information is mandatory: Sample time point (Chemotherapy time points); Previous diagnostic immunophenotype report; Clinical History to include if patient is on anti-CD38 therapy; Original TRF; Date and time when sample was drawn.

Test Details

The Multiple Myeloma Comprehensive Profile test is a diagnostic tool used to evaluate and monitor multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This test provides a comprehensive analysis of various markers and genetic abnormalities associated with multiple myeloma. The test typically includes the following components:

  1. Complete Blood Count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in the blood. Abnormalities in these cell counts can indicate the presence of multiple myeloma.
  2. Serum Protein Electrophoresis (SPEP): This test separates proteins in the blood and measures the levels of different types of proteins, including immunoglobulins (IgG, IgA, IgM). Abnormal levels of these proteins can indicate the presence of multiple myeloma.
  3. Urine Protein Electrophoresis (UPEP): This test evaluates the presence of abnormal proteins in the urine, such as Bence Jones proteins. Bence Jones proteins are often associated with multiple myeloma.
  4. Serum Free Light Chain Assay: This test measures the levels of free light chains (kappa and lambda) in the blood. Abnormal levels of these light chains can indicate the presence of multiple myeloma.
  5. Beta-2 Microglobulin: This test measures the levels of beta-2 microglobulin, a protein that is often elevated in multiple myeloma.
  6. Cytogenetic Analysis: This test examines the genetic abnormalities present in the cancer cells. Common abnormalities in multiple myeloma include translocations involving the immunoglobulin genes.
  7. Fluorescence In Situ Hybridization (FISH): This test uses fluorescent probes to identify specific genetic abnormalities, such as deletions or translocations, in the cancer cells.
  8. Bone Marrow Aspiration and Biopsy: This procedure involves extracting a sample of bone marrow for examination under a microscope. It helps determine the percentage of plasma cells present and assess the overall health of the bone marrow.

The Multiple Myeloma Comprehensive Profile test provides valuable information for diagnosing and monitoring multiple myeloma. It helps healthcare professionals develop personalized treatment plans and evaluate the response to therapy.

Test Name MULTIPLE MYELOMA COMPREHENSIVE PROFILE Test
Components *CBC*Urea*Creatinine*Calcium, total *Albumin*LDH *Beta 2 Microglobulin *Protein electrophoresis, serum*Immunotyping, serum*Kappa / Lambda Light Chains Free, serum *Immunoglobulin Profile, serum*MRD for Multiple Myeloma
Price 3510.0 AED
Sample Condition 5 mL (3 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Overnight fasting is preferred AND 3 mL (1 mL min.) Bone Marrow (first pull aspirate) in 1 Green Top (Sodium Heparin) tube AND 1 or 2 unstained Bone marrow smears to be made at source. Mix thoroughly & Ship immediately at18-22?\u00f8C or at 4-8?\u00f8C. DO NOT FREEZE. Following information is mandatory:\nSample time point (Chemotherapy time points); Previous diagnostic immunophenotype report; Clinical History to include if patient is on anti-CD38 therapy; Original TRF;Date and time when sample was drawn.
Report Delivery Sample Daily by 9 am; Report 3 Working days
Method Capillary electrophoresis,Agarose Gel Electrophoresis, Immunoturbidimetry,CLIASpectrophotometry, Electrical impedence, VCSNephelometry, Flow cytometry
Test type Multiple Myeloma
Doctor Oncologist
Test Department: FLOW CYTOMETRY
Pre Test Information Overnight fasting preferred. Following information is mandatory: Sample time point (Chemotherapy time points); Previous diagnostic immunophenotype report; Clinical History to include if patient is on anti-CD38 therapy; Original TRF;Date and time when sample was drawn.
Test Details

The Multiple Myeloma Comprehensive Profile test is a diagnostic tool used to evaluate and monitor multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This test provides a comprehensive analysis of various markers and genetic abnormalities associated with multiple myeloma.

The test typically includes the following components:

1. Complete Blood Count (CBC): This test measures the number of red blood cells, white blood cells, and platelets in the blood. Abnormalities in these cell counts can indicate the presence of multiple myeloma.

2. Serum Protein Electrophoresis (SPEP): This test separates proteins in the blood and measures the levels of different types of proteins, including immunoglobulins (IgG, IgA, IgM). Abnormal levels of these proteins can indicate the presence of multiple myeloma.

3. Urine Protein Electrophoresis (UPEP): This test evaluates the presence of abnormal proteins in the urine, such as Bence Jones proteins. Bence Jones proteins are often associated with multiple myeloma.

4. Serum Free Light Chain Assay: This test measures the levels of free light chains (kappa and lambda) in the blood. Abnormal levels of these light chains can indicate the presence of multiple myeloma.

5. Beta-2 Microglobulin: This test measures the levels of beta-2 microglobulin, a protein that is often elevated in multiple myeloma.

6. Cytogenetic Analysis: This test examines the genetic abnormalities present in the cancer cells. Common abnormalities in multiple myeloma include translocations involving the immunoglobulin genes.

7. Fluorescence In Situ Hybridization (FISH): This test uses fluorescent probes to identify specific genetic abnormalities, such as deletions or translocations, in the cancer cells.

8. Bone Marrow Aspiration and Biopsy: This procedure involves extracting a sample of bone marrow for examination under a microscope. It helps determine the percentage of plasma cells present and assess the overall health of the bone marrow.

The Multiple Myeloma Comprehensive Profile test provides valuable information for diagnosing and monitoring multiple myeloma. It helps healthcare professionals develop personalized treatment plans and evaluate the response to therapy.

SKU: TEST-4726